1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

✍ Scribed by Grzasko, Norbert; Hus, Marek; Chocholska, Sylwia; Pluta, Andrzej; Hajek, Roman; Dmoszynska, Anna

• Book ID: 121273986
• Publisher: Informa plc
• Year: 2012
• Tongue: English
• Weight: 265 KB
• Volume: 53
• Category: Article
• ISSN: 1042-8194
• DOI: 10.3109/10428194.2012.684349